Skip to main content
Essex Bio-Technology Limited logo

Essex Bio-Technology Limited — Investor Relations & Filings

Ticker · 1061 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1061

About Essex Bio-Technology Limited

http://www.essexbio.com

Essex Bio-Technology Limited is a bio-pharmaceutical company specializing in the development, manufacture, and commercialization of genetically engineered therapeutic Fibroblast Growth Factors (FGFs), particularly recombinant bovine basic FGF (rb-bFGF). The company utilizes recombinant DNA technology to produce biologic drugs aimed at the treatment and healing of surface and organ wounds. Its portfolio includes six flagship biologics approved for a wide range of indications across key therapeutic areas: Ophthalmology, Dermatology, and Wound Healing. Leveraging an in-house R&D platform focused on growth factors and antibodies, the company maintains an active pipeline of projects. Its commercial reach extends to over 14,100 hospitals, supported by 46 regional sales offices.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Regulatory Filings Classification · 1% confidence The document is a routine monthly return (Form FF301) filed with the Hong Kong Stock Exchange under Chapter 19B of the Exchange Listing Rules, reporting movements in share capital, issued shares, public float sufficiency, share option schemes, etc. It is not an earnings release, management discussion, M&A notice, dividend notice, nor an AGM or investor presentation. It is a mandatory listing‐rules regulatory submission that does not match any more specific category, so it falls under the general Regulatory Filings category (RNS).
2026-04-01 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “NOTICE OF ANNUAL GENERAL MEETING” and consists of a formal notice sent to shareholders detailing the date, time, venue, agenda items, resolutions, proxy instructions, and voting procedures. It is not the full Annual Report nor a slide deck, but rather the solicitation of proxies and informational statement for the AGM. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-31 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 26 MAY 2026 (or any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a FORM OF PROXY for the Annual General Meeting of Essex Bio-Technology Limited, providing shareholders with instructions on appointing proxies and voting on AGM resolutions. This is part of proxy solicitation materials sent to shareholders to request votes, which falls under Proxy Solicitation & Information Statement (PSI). It is not the AGM notice itself, not an earnings release, and not a voting results announcement.
2026-03-31 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information Classification · 1% confidence The document is titled “2025 Environmental, Social and Governance Report” and contains detailed disclosures on ESG strategy, environmental performance, social initiatives, governance practices, reporting standards and stakeholder engagement for the year ended 31 December 2025. It is a standalone ESG report prepared in accordance with GRI and Hong Kong ESG Reporting Code. This matches the definition of an Environmental & Social Information report (Code: SR).
2026-03-31 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an AGM circular/proxy statement: it provides notice of the Annual General Meeting, details resolutions for shareholder voting (general mandates to issue and repurchase shares, re-election of directors, dividend declaration, auditor appointment), and includes a form of proxy. It is not the company’s annual report or financial statements themselves, nor a simple announcement of publication; rather it is seeking shareholder votes. This matches the definition of a Proxy Solicitation & Information Statement (Code: PSI).
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.